Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Prioritized List Transition topic
No spam. Unsubscribe anytime.
Heated hearing on HB 4,003 over transition of Oregon’s Medicaid 'prioritized list' into state plan
Summary
The House Healthcare Committee heard extensive pro and con testimony on HB 4,003, a technical bill to move the Medicaid prioritized list from an 1115 waiver into the state plan and remove the statutory "funding line" and ranking. OHA said the measure is needed for federal compliance and preserves HERC's clinical role; former Governor Kitzhaber and many providers urged caution, warning of loss of transparency and added administrative burden.
House Bill 4,003 drew some of the most extended debate of the evening as the Oregon Health Authority explained a federally required transition: CMS directed that Oregon phase out certain features of the prioritized list by Jan. 1, 2027 and align the benefit package with a state plan amendment. OHA Director Sejal Hathy and Oregon Medicaid Director Emma Sando told the committee the bill removes the funding line and formal ranking from statute while preserving the Health Evidence Review Commission’s (HERC) role in developing clinical criteria, scope, amount and duration for services.
OHA officials described the measure as narrowly tailored to meet CMS requirements while minimizing operational change: clinical guideline notes, treatment/code pairings and HERC’s evidence‑review processes would remain, but the list would reflect covered versus not‑covered services rather than a rank‑ordered funding line.
Opponents mounted a sustained challenge. Former Governor John Kitzhaber testified that statutory changes are unnecessary and risky, arguing the amendments would move decision‑making away from the transparent, evidence‑based HERC process into OHA administration and would create confusion, litigation risk and additional administrative burden. Providers and CCO representatives from rural areas warned the shift could increase prior authorizations, depress rates when more services are considered mandatory, and undermine the predictable authorization pathways clinicians and patients rely on.
Supporters of the bill (including participants in the benefit‑update work group and the Oregon Law Center) said the measure creates a statutory framework needed to align state law with the state plan, clarify appeals pathways and establish individual medical‑review processes that currently are difficult for members to navigate.
Committee members pressed OHA on definitions of medical necessity, legislative oversight and whether the changes would increase prior authorization or materially change benefits. OHA repeated that HERC’s evidence‑based review will continue and said the amendment requires OHA to consult HERC before any significant reductions.
Chair Noss closed the public hearing and announced a work session next week; members were urged to study the dash‑1 amendment and consult stakeholders before the session reconvenes.
